# A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer

> **NCT02137083** · PHASE2 · COMPLETED · sponsor: **Fudan University** · enrollment: 22 (actual)

## Conditions studied

- Metastatic Breast Cancer

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Fulvestrant

## Key facts

- **NCT ID:** NCT02137083
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02137083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02137083, "A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT02137083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*